Skip to search formSkip to main contentSkip to account menu

B 669

Known as: 2-Phenazinamine, 3-(cyclohexylimino)-3,5-dihydro-N,5-diphenyl-, B-669, B669 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Clofazimine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
are mediated by lysophospholipids. Antimicrobial activities of clofazimine and B669
a-tocopherolcomplexeswithfattyacids. Natureofcomplexes.Biochim. Biophys. Acta815:209-214.14. Imkamp, F. M. J. H. 1968. Atreatment… 
2007
2007
The Riminophenazine Agents Clofazimine and B 669 Inhibit the Proliferation of Cancer Cell Lines in Vitro by Phospholipase Az-mediated Oxidative and Nonoxidative Mechanisms
Clofazimine, a riminophenazine antimicrobial agent, and its analogue B669 were investigated for their effects on FaDu cells, a… 
2004
2004
Tetramethylpiperidine-Substituted Phenazines Inhibit the Proliferation of Intrinsically Multidrug Resistant Carcinoma Cell Lines
The effects of nine newtetramethylpiperidine (TMP)-substitutedphenazines on the growth of a humanesophageal cancer cell line… 
1996
1996
Chemosensitizing interactions of clofazimine and B669 with human K562 erythroleukaemia cells with varying levels of expression of P-glycoprotein.
1996
1996
The riminophenazine agents clofazimine and B669 inhibit the proliferation of intrinsically multidrug resistant carcinoma cell lines.
The sensitivity to clofazimine, B669 and eight standard anti-tumour chemotherapeutic agents of four intrinsically multidrug… 
1995
1995
The pro-oxidative riminophenazine B669 neutralizes the inhibitory effects of Mycobacterium tuberculosis on phagocyte antimicrobial activity.
1994
1994
The riminophenazine agents clofazimine and B669 reverse acquired multidrug resistance in a human lung cancer cell line.
1994
1994
The antiproliferative riminophenazine agents clofazimine and b669 promote lysophospholipid-mediated inhibition of na+, k+-adenosine triphosphatase-activity in cancer cell-lines in-vitro.
The effects of the anti-proliferative, phospholipase A(2) (PLA(2))-activating riminophenazine agents, clofazimine and B669, on… 
1994
1994
An in-vitro investigation of the susceptibility of Enterococcus faecalis to clofazimine and B669.
1993
1993
Evaluation of the antineoplastic activities of the riminophenazine agents clofazimine and b669 in tumor-bearing rats and mice.
The riminophenazine agents clofazimine and its analogue B669 displayed anti-tumor activity at 30 mg/kg/day in benzo[a]pyrene (BP… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)